| 16/01 | Kane Biotech: DermaKB™ Offers Personalized Scalp Solutions Developed by Kane Biotec.. |  |
| 04/01 | Kane Biotech Announces First Distribution Agreement for its Coactiv+ Antimicrobial Hydr.. | |
| 04/01 | Kane Biotech Announces First Distribution Agreement for its coactiv+™ Antimicrobi.. | |
| 04/01 | Kane Biotech Inc. Announces First Distribution Agreement for coactiv+™ Antimicrobi.. | |
| 2022 | Kane Biotech Inc. Reaches an Agreement to Obtain Loans in the Aggregate Amount of $2,00.. | |
| 2022 | Kane Biotech Announces Loan Transaction | |
| 2022 | Kane Biotech Third-Quarter Loss Narrows on Higher Sales and Lower Expenses | |
| 2022 | Kane Biotech Announces Third Quarter 2022 Financial Results | |
| 2022 | Kane Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended .. | |
| 2022 | Kane Biotech to Release Third Quarter 2022 Financial Results on November 24, 2022 &nda.. | |
| 2022 | Kane Biotech Announces 510 Submission for its coactiv+ Antimicrobial Hydrogel | |
| 2022 | Kane Biotech Announces 510(k) Submission for its coactiv+™ Antimicrobial Hydrogel | |
| 2022 | Kane Biotech Inc. Announces 510(K) Submission for Its Coactiv+™ Antimicrobial Hydr.. | |
| 2022 | Kane Biotech to Present at Symposium on Advanced Wound Care Fall Forum | |
| 2022 | Kane Biotech Receives an Additional $425K USD of Funding for its DispersinB® Hydrogel f.. | |
| 2022 | Kane Biotech: Three and six months ended June 30, 2022 | |
| 2022 | Kane Biotech: Three and six months ended June 30, 2022 | |
| 2022 | Kane Biotech Announces Second Quarter 2022 Financial Results | |
| 2022 | Kane Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended .. | |
| 2022 | Kane Biotech to Release Second Quarter 2022 Financial Results on August 25, 2022 &ndash.. | |
| 2022 | Kane Biotech Announces Adoption of Amended and Restated Stock Option Plan and Performan.. | |
| 2022 | Kane Biotech Announces Amended Credit Facility | |
| 2022 | Kane Biotech Inc. Announces Amended Credit Facility | |
| 2022 | Kane Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022 | |
| 2022 | Kane Biotech First-Quarter Loss Widens as Sales Rise by 50% | |
| 2022 | Kane Biotech Announces First Quarter 2022 Financial Results | |
| 2022 | Kane Biotech to Release First Quarter 2022 Financial Results on May 26 - Conference Cal.. | |
| 2022 | Kane Biotech to Release First Quarter 2022 Financial Results on May 26 – Conferen.. | |
| 2022 | Kane Biotech Obtains ISO 13485 Certification | |
| 2022 | Kane Biotech Announces Closing of Private Placement | |
| 2022 | Kane Biotech Obtains ISO 13485 Certification | |
| 2022 | Kane Biotech Inc. announced that it has received CAD 1 million in funding | |
| 2022 | Kane Biotech Announces Update on Private Placement | |
| 2022 | Kane Biotech Provides Update on $1 Million Private Placement | |
| 2022 | Kane Biotech Reports Extension of Private Placement | |
| 2022 | Kane Biotech: Three Months and Full Year Ended December 31, 2021 | |
| 2022 | Kane Biotech Inc. - STEM Animal Health Awarded Veterinary Oral Health Council Seal of A.. | |
| 2022 | STEM Animal Health Awarded Veterinary Oral Health Council Seal of Acceptance for Pet Or.. | |
| 2022 | IIROC Trading Resumption - KNE | |
| 2022 | STEM Animal Health Awarded Veterinary Oral Health Council (VOHC) Seal of Acceptance for.. | |
| 2022 | IIROC Trading Halt - KNE | |
| 2022 | Kane Biotech Appoints Dr. Gregory Schultz as Chief Scientific Officer | |
| 2022 | Kane Biotech Appoints Dr. Gregory Schultz as Chief Scientific Officer | |
| 2022 | Kane Biotech Inc. Appoints Dr. Gregory Schultz as Chief Scientific Officer | |
| 2022 | Kane Biotech: Biofilm Research Leads to Folliculitis Relief | |
| 2022 | Kane Biotech Fourth-Quarter Loss Widens as Higher Costs Offset Sales Gains | |
| 2022 | Kane Biotech Brief: Cash at December 31, 2021 was $1,153,090 Vs $1,00.. | |
| 2022 | Kane Biotech Brief: Loss for Q4 2021 was $(1,257,173) Vs $(945,795) f.. | |
| 2022 | Kane Biotech Brief: Total Revenue for Q4 was $411,693, an increase of.. | |
| 2022 | Kane Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2021 | |
| 2022 | Kane Biotech Announces Fourth Quarter and Full Year 2021 Financial Results | |
| 2022 | Kane Biotech Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 20.. | |
| 2022 | Kane Biotech Inc. Auditor Raises 'Going Concern' Doubt | |
| 2022 | Kane Biotech Completes Safety and Biocompatibility Studies for DispersinB Wound Gel in .. | |
| 2022 | Kane Biotech Successfully Completes Safety and Biocompatibility Studies for DispersinB®.. | |
| 2022 | Kane Biotech Successfully Completes Safety and Biocompatibility Studies for DispersinB .. | |
| 2022 | Kane Biotech to Release Fourth Quarter and Full Year 2021 Financial Results on March 24.. | |
| 2022 | Kane Biotech Announces Private Placement Offering | |
| 2022 | Kane Biotech Inc. announced that it expects to receive CAD 1 million in funding | |
| 2022 | Kane Biotech: Personal DermaKB™ Stories Meet Rina Grasman | |
| 2022 | Kane Biotech Announces New Collaboration Agreements for Prosthetic Joint Infection, Exp.. | |
| 2022 | Kane Biotech Announces New Collaboration Agreements for Prosthetic Joint Infection, Exp.. | |
| 2022 | Kane Biotech Announces New Collaboration Agreements for Prosthetic Joint Infection, exp.. | |
| 2022 | Kane Biotech Says Wound Care Commercialization to be Key Company Focus in 2022 | |
| 2022 | Wound Care Commercialization to be a Key Company Focus in 2022 | |
| 2021 | Kane Biotech: Three and Nine Months Ended September 30, 2021 | |
| 2021 | Kane Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended .. | |
| 2021 | Kane Biotech Third-Quarter Loss Widens Despite Sales Gain | |
| 2021 | Kane Biotech Announces Third Quarter 2021 Financial Results | |
| 2021 | Kane Biotech to Release Third Quarter 2021 Financial Results on November 16 – Con.. | |
| 2021 | Kane Biotech Announces New Credit Facility | |
| 2021 | Kane Biotech Inc. Announces New Credit Facility | |
| 2021 | Kane Biotech : STEM Animal Health Completes First Shipment of Bluestem Oral.. | |
| 2021 | STEM Animal Health completes first shipment of bluestem™ oral care products to Pe.. | |
| 2021 | Kane Biotech Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021 | |
| 2021 | Kane Biotech: Announces Second Quarter 2021 Financial Results | |
| 2021 | Kane Biotech: to Release Second Quarter 2021 Financial Results on August 26 – Confe.. | |
| 2021 | Kane Biotech : Expands Wound Care and Surgical Portfolio With Antimicrobial.. | |
| 2021 | Kane Biotech: Expands its Wound Care and Surgical Portfolio with a coactiv+TM Antimicrobi.. | |
| 2021 | Kane Biotech Inc. Expands its Wound Care and Surgical Portfolio with a coactiv+TM Antim.. | |
| 2021 | Kane Biotech: Announces Cancellation of Options and Issuance of Restricted Share Units | |
| 2021 | Kane Biotech : Announces Key Milestones as Wound Care Project Advances to H.. | |
| 2021 | Kane Biotech announces two key milestones as DispersinB® wound care project advances to.. | |
| 2021 | Kane Biotech Inc. Prepares its First Batch of DispersinB® | |
| 2021 | Kane Biotech Inc. Announces New Manufacturing Partnership with Dow Development Laborato.. | |
| 2021 | Kane Biotech to meet investors at Whistler 2021 Capital Conference | |
| 2021 | Kane Biotech launches 2021 business update series | |
| 2021 | Kane Biotech Announces Adoption of Performance and Restricted Share Unit Plan and Amend.. | |
| 2021 | Kane Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021 | |
| 2021 | Kane Biotech : First Quarter Loss Narrows Despite Sales Drop | |
| 2021 | Kane Biotech Announces First Quarter 2021 Financial Results | |
| 2021 | Kane Biotech : Announces "Strong Positive Results" of DermaKB Shampoo Consu.. | |
| 2021 | Kane Biotech Announces Strong Positive Results of DermaKB™ Shampoo Consumer Trial | |
| 2021 | Kane Biotech Inc. Announces Strong Positive Results of DermaKB™ Shampoo Consumer Trial | |
| 2021 | Kane Biotech Strengthens Board with Biotech Executive | |
| 2021 | Kane Biotech Appoints Allan Mandelzys as an Advisor to Board of Directors | |
| 2021 | Kane Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2020 | |
| 2021 | Kane Biotech Fourth-Quarter Loss Narrows Even as Revenue Falls 54% | |
| 2021 | Kane Biotech Announces Fourth Quarter and Full Year 2020 Financial Results | |
| 2021 | Kane Biotech Inc. Auditor Raises 'Going Concern' Doubt | |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Nederlands (Nederland)
Nederlands (België)
